test44
https://www.cytel.com/blog/the-uses-of-bayesian-methods-in-late-phase-clinical-trial-strategy
August 3, 2022
A number of late-phase clinical trial sponsors remain hesitant to employ Bayesian approaches in confirmatory settings,..
Read article
test44
https://www.cytel.com/blog/advancing-clinical-trials-with-digital-tools-simulation-guided-design
test44
https://www.cytel.com/blog/new-directions-in-indirect-treatment-comparisons
July 28, 2022
When new treatments are compared with existing therapies in clinical care, population-adjustment techniques need to..
Read article
test44
https://www.cytel.com/blog/adaptive-designs-are-once-again-re-defining-drug-development
July 27, 2022
Written by Jing Ping Yeo and Charles Warne Adaptive designs are studies that “include a prospectively planned..
Read article
test44
https://www.cytel.com/blog/7-ways-rwd-is-transforming-clinical-research
July 26, 2022
Many thanks to Grammati Sarri and Michael Groff for their comments in developing this blog. The ability to draw on..
Read article
test44
https://www.cytel.com/blog/the-case-for-network-meta-interpolation-to-handle-effect-modifiers-in-indirect-treatment-comparisons
July 20, 2022
When performing indirect treatment comparisons, effect modification can create complexities in the event of high..
Read article
test44
https://www.cytel.com/blog/5-steps-to-adjust-for-effect-modifiers-for-population-adjusted-indirect-treatment-comparisons
July 13, 2022
Many thanks to Grammati Sarri and Michael Groff for their comments in developing this blog. An indirect treatment..
Read article
test44
https://www.cytel.com/blog/strategies-for-selecting-new-indications-for-a-platform-trial
July 12, 2022
Thanks to Dr. Kyle Wathen for comments on this blog. The increasing use of platform trials for the testing of a wide..
Read article
test44
https://www.cytel.com/blog/using-quantitative-bias-analysis-in-real-world-data-strategy
July 7, 2022
The gold standard for assessing the efficacy for a medicine continues to be RCTs, however, for many reasons (disease..
Read article